MALIGNANT PLASMA CELL NEOPLASMS

Clinical trials for MALIGNANT PLASMA CELL NEOPLASMS explained in plain language.

Never miss a new study

Get alerted when new MALIGNANT PLASMA CELL NEOPLASMS trials appear

Sign up with your email to follow new studies for MALIGNANT PLASMA CELL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New combo therapy aims to control plasma cell cancer

Disease control Not yet recruiting

This study tests a new drug called QLS4131, given as a shot under the skin, combined with other medicines for people with malignant plasma cell neoplasms, a group of blood cancers including multiple myeloma. The goal is to see if these combinations are safe and help shrink or con…

Matched conditions: MALIGNANT PLASMA CELL NEOPLASMS

Phase: PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated May 07, 2026 18:38 UTC

MALIGNANT PLASMA CELL NEOPLASMS

Get alerted when new MALIGNANT PLASMA CELL NEOPLASMS trials appear

New combo therapy aims to control plasma cell cancer